Aranesp - 54868-5429-0 - (darbepoetin alfa)

Alphabetical Index


Drug Information of Aranesp

Product NDC: 54868-5429
Proprietary Name: Aranesp
Non Proprietary Name: darbepoetin alfa
Active Ingredient(s): 300    ug/.6mL & nbsp;   darbepoetin alfa
Administration Route(s): INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Aranesp

Product NDC: 54868-5429
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103951
Marketing Category: BLA
Start Marketing Date: 20080320

Package Information of Aranesp

Package NDC: 54868-5429-0
Package Description: 1 BLISTER PACK in 1 PACKAGE (54868-5429-0) > 1 SYRINGE in 1 BLISTER PACK > .6 mL in 1 SYRINGE

NDC Information of Aranesp

NDC Code 54868-5429-0
Proprietary Name Aranesp
Package Description 1 BLISTER PACK in 1 PACKAGE (54868-5429-0) > 1 SYRINGE in 1 BLISTER PACK > .6 mL in 1 SYRINGE
Product NDC 54868-5429
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name darbepoetin alfa
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 20080320
Marketing Category Name BLA
Labeler Name Physicians Total Care, Inc.
Substance Name DARBEPOETIN ALFA
Strength Number 300
Strength Unit ug/.6mL
Pharmaceutical Classes Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE]

Complete Information of Aranesp


General Information